Safety and Clinical Performance of the Protecta ICD and CRT-D

NCT ID: NCT00982397

Last Updated: 2017-11-06

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

2770 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-09-30

Study Completion Date

2013-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the study is two-fold. In Phase I (Protecta Clinical Study), system performance will be evaluated. In Phase II (PainFree SST), the inappropriate shock-free rate at one year of subjects implanted with a Medtronic Protecta implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) will be evaluated.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The PainFree SST study was a prospective, multicenter clinical trial, which was conducted in two consecutive phases. Phase I assessed safety as determined by assessment of delays in ventricular fibrillation (VF) arrhythmia detection time using new algorithms. Phase II assessed the influence of new algorithms on inappropriate and unnecessary shocks at 1 year of follow-up. Subjects enrolled in Phase I continued in Phase II of the study and data from all enrolled subjects contributed to the analysis of Phase II objectives. A sub-study of Phase II randomized secondary prevention subjects to either 18/24 NID or 30/40 NID in order to assess the safety of prolonged detection in these patients.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Tachyarrhythmias Heart Failure Ventricular Dysfunction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Single-chamber detetction

Patients implanted with a Protecta VR-ICD.

Group Type EXPERIMENTAL

Protecta VR-ICD

Intervention Type DEVICE

Protecta single-chamber implantable cardioverter defibrillators.

Dual-chamber detection

Patients implanted with a Protecta DR-ICD or CRT-D.

Group Type EXPERIMENTAL

Protecta DR-ICD or CRT-D

Intervention Type DEVICE

Protecta dual-chamber implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Protecta VR-ICD

Protecta single-chamber implantable cardioverter defibrillators.

Intervention Type DEVICE

Protecta DR-ICD or CRT-D

Protecta dual-chamber implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients meeting one of the following criteria can be included in Phase I of the study:

* Patients indicated (per local indications) for a dual chamber implantable cardioverter defibrillator (DR-ICD)/cardiac resynchronization therapy defibrillator (CRT-D)
* Patients undergoing a device replacement or upgrade to DR-ICD or CRT-D and with the protocol required leads (patients must be enrolled prior to implant)
* Patients meeting one of the following criteria can be included in Phase II of the study:

* Patients indicated for a DR-ICD/VR-ICD/CRT-D device and intended to receive a Protecta device
* Patients undergoing a DR-ICD/VR-ICD/CRT-D device replacement or an upgrade to a Protecta DR-ICD/VR-ICD or CRT-D
* Patients indicated for a DR-ICD/VR-ICD/CRT-D already implanted with a Protecta device and the protocol required leads, who have not yet been discharged after implant

Exclusion Criteria

* Patients with a mechanical tricuspid heart valve
* Patients enrolled or intended to participate in any concurrent drug and/or device study, which would confound the results of this trial as determined by Medtronic, during the course of this clinical study
* Patients with medical conditions that preclude the testing required for all patients by the study protocol or that otherwise limit study participation required for all patients
* Patients anticipated not being able to complete the study
* Patients unwilling to provide written informed consent
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Medtronic Cardiac Rhythm and Heart Failure

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

A. Meijer, Dr.

Role: PRINCIPAL_INVESTIGATOR

Eindhoven, The Netherlands

A. Auricchio, Prof.

Role: PRINCIPAL_INVESTIGATOR

Lugano, Switzerland

T. Kurita, Dr.

Role: PRINCIPAL_INVESTIGATOR

Higashi-Osaka, Japan

E.J. Schloss, Dr.

Role: PRINCIPAL_INVESTIGATOR

Cincinnati Ohio, USA

L. Sterns, Dr.

Role: PRINCIPAL_INVESTIGATOR

Victoria, British Columbia, Canada

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Birmingham Heart Clinic PC

Birmingham, Alabama, United States

Site Status

CardioVasular Associates of Mesa

Mesa, Arizona, United States

Site Status

Mercy Hospital Fort Smith

Fort Smith, Arkansas, United States

Site Status

LA Cardiology Associates

Los Angeles, California, United States

Site Status

Cardiology Consultants of Napa Valley

Napa, California, United States

Site Status

Hartford Hospital

Hartford, Connecticut, United States

Site Status

University of Florida Health at Jacksonville

Jacksonville, Florida, United States

Site Status

Arrhythmia Syncope Consultants LLC

Miami, Florida, United States

Site Status

Indiana Heart Physicians

Indianapolis, Indiana, United States

Site Status

Cardiovascular Research of Northwest Indiana

Munster, Indiana, United States

Site Status

Iowa Heart Center

West Des Moines, Iowa, United States

Site Status

Delmarva Heart Research Foundation

Salisbury, Maryland, United States

Site Status

Essentia Institute of Rural Health

Duluth, Minnesota, United States

Site Status

CentraCare Heart & Vascular Center

Saint Cloud, Minnesota, United States

Site Status

Saint John's Medical Research Inc

Springfield, Missouri, United States

Site Status

Saint Louis Heart & Vascular PC

St Louis, Missouri, United States

Site Status

Cardiology PC

Syracuse, New York, United States

Site Status

Pinehurst Medical Clinic

Pinehurst, North Carolina, United States

Site Status

Ohio Heart and Vascular

Cincinnati, Ohio, United States

Site Status

St. Vincent Mercy Medical Center

Toledo, Ohio, United States

Site Status

Central Bucks Cardiology

Doylestown, Pennsylvania, United States

Site Status

University of Pennsylvania

Philadelphia, Pennsylvania, United States

Site Status

Pee Dee Cardiology

Florence, South Carolina, United States

Site Status

Cardiology Consultants PA

Spartanburg, South Carolina, United States

Site Status

Centennial Heart Cardiovascular Consultants LLC

Nashville, Tennessee, United States

Site Status

Hall-Garcia Cardiology Associates

Houston, Texas, United States

Site Status

Virginia Commonwealth University Health System

Richmond, Virginia, United States

Site Status

Spokane Cardiology

Spokane, Washington, United States

Site Status

Columbia St. Mary's Hospital

Milwaukee, Wisconsin, United States

Site Status

LKH - Universitätsklinikum Graz

Graz, , Austria

Site Status

Landesklinikum St. Pölten

Sankt Pölten, , Austria

Site Status

Klinikum Wels-Grieskirchen GmbH

Wels, , Austria

Site Status

Saint Paul's Hospital (Vancouver BC)

Vancouver, British Columbia, Canada

Site Status

Royal Jubilee Hospital

Victoria, British Columbia, Canada

Site Status

Institut Universitaire de Cardiologieet de Pneumologie de Québec (IUCPQ)

Halifax, Nova Scotia, Canada

Site Status

Newmarket Electrophysiology Research Group

Newmarket, Ontario, Canada

Site Status

Queen Elizabeth II Health Sciences Centre

Halifax, , Canada

Site Status

Kelowna Arrhythmia Research

Kelowna, , Canada

Site Status

Queen's University & Kingston General Hospital

Kingston, , Canada

Site Status

London Health Sciences Centre - University Campus

London, , Canada

Site Status

Montreal Heart Institute

Montreal, , Canada

Site Status

University of Ottawa Heart Institute

Ottawa, , Canada

Site Status

Fundacion Cardioinfantil

Bogotá, , Colombia

Site Status

Hospital Cardiovascular del Nino

Bogotá, , Colombia

Site Status

Clinica Cardiovascular Santa Maria

Medellín, , Colombia

Site Status

Krajska nemocnice Liberec a.s. - Kardiocentrum

Liberec, , Czechia

Site Status

Aalborg Sygehus

Aalborg, , Denmark

Site Status

Aarhus Universitetshospital - Skejby

Aarhus, , Denmark

Site Status

Herz- und Gefässzentrum Bad Bevensen

Bad Bevensen, , Germany

Site Status

Herz- und Diabeteszentrum NRW - Ruhr-Universität Bochum

Bad Oeynhausen, , Germany

Site Status

Segeberger Kliniken GmbH

Bad Segeberg, , Germany

Site Status

Berufsgenossenschaftliche Universitätsklinik Bergmannsheil GmbH

Bochum, , Germany

Site Status

Universitätsklinikum Bonn

Bonn, , Germany

Site Status

MVZ am Küchwald GmbH ambulantes Herz Zentrum Chemnitz

Chemnitz, , Germany

Site Status

Klinikum Coburg GmbH

Coburg, , Germany

Site Status

Kardiocentrum Frankfurt an der Klinik Rotes Kreuz

Frankfurt, , Germany

Site Status

Universitätsmedizin Göttingen Georg-August-Universität

Göttingen, , Germany

Site Status

Ruprecht-Karls-Universität

Heidelberg, , Germany

Site Status

Westpfalz-Klinikum GmbH - Standort I Kaiserslautern

Kaiserslautern, , Germany

Site Status

Herz Zentrum Bodensee

Konstanz, , Germany

Site Status

Klinikum Ludwigsburg - Akademisches Lehrkrankenhaus der Universität Heidelberg

Ludwigsburg, , Germany

Site Status

Universitätsmedizin der Johannes Gutenberg-Universität Mainz

Mainz, , Germany

Site Status

Städtische Kliniken München GmbH - Klinikum Bogenhausen

München, , Germany

Site Status

Städtische Kliniken Neuss Lukaskrankenhaus GmbH-Akad.Lehrkrankenhaus d. Heinrich-Heine-Universität

Neuss, , Germany

Site Status

Universitätsmedizin Rostock

Rostock, , Germany

Site Status

Herz- und Kreislaufzentrum Rotenburg a.d. Fulda GmbH

Rotenburg A.d. Fulda, , Germany

Site Status

Asklepios Kliniken Schwalm - Eder GmbH - Klinikum Schwalmstadt

Schwalmstadt, , Germany

Site Status

Heinrich-Braun-Klinikum Zwickau gemeinnützige GmbH

Zwickau, , Germany

Site Status

Care Institute of Medical Sciences

Ahmedabad, , India

Site Status

Medanta-The Medicity

Gurgaon, , India

Site Status

Barzilai Medical Center Ashkelon

Ashkelon, , Israel

Site Status

Soroka University Medical Center

Be'er Sheba, , Israel

Site Status

Carmel Medical Center

Haifa, , Israel

Site Status

Rambam Health Care Campus

Haifa, , Israel

Site Status

Shaare Zedek Medical Center

Jerusalem, , Israel

Site Status

Rabin Medical Center - Beilinson Hospital

Petah Tikva, , Israel

Site Status

Chaim Sheba Medical Center

Ramat Gan, , Israel

Site Status

Kaplan Medical Center

Rehovot, , Israel

Site Status

Tel Aviv Sourasky Medical Center

Tel Aviv, , Israel

Site Status

Ospedale classificato ed equiparato Sacro Cuore - Don Calabria

Negrar, , Italy

Site Status

Azienda Complesso Ospedaliero San Filippo Neri - Ospedale San Filippo Neri

Rome, , Italy

Site Status

Hirosaki University School of Medicine & Hospital

Hirosaki, Aomori, Japan

Site Status

Kansai Rosai Hospital

Amagasak, Hyōgo, Japan

Site Status

Kobe University Hospital

Kobe, Hyōgo, Japan

Site Status

St. Marianna University School of Medicine Hospital

Kawasaki, Kanagawa, Japan

Site Status

Kinki University Hospital

Osakasaya, Osaka, Japan

Site Status

National Cerebral and Cardiovasuclar Center

Suita, Osaka, Japan

Site Status

Sapporo Medical Center NTT EC

Chūōku, Sapporo, Japan

Site Status

Akita Medical Center

Akita, , Japan

Site Status

Chiba University Hospital

Chiba, , Japan

Site Status

Kokura Memorial Hospital

Kitakyushu, , Japan

Site Status

Kumamoto University Hospital

Kumamoto, , Japan

Site Status

Kyoto University Hospital

Kyoto, , Japan

Site Status

Niigata University Medical & Dental Hospital

Niigata, , Japan

Site Status

Kitasato University Hospital

Sagamihara, , Japan

Site Status

Institut Jantung Negara - National Heart Institute

Kuala Lumpur, , Malaysia

Site Status

Medisch Centrum Alkmaar

Alkmaar, , Netherlands

Site Status

Academisch Medisch Centrum (AMC)

Amsterdam, , Netherlands

Site Status

Amphia Ziekenhuis - Locatie Molengracht Breda

Breda, , Netherlands

Site Status

Catharina Ziekenhuis

Eindhoven, , Netherlands

Site Status

Medisch Spectrum Twente

Enschede, , Netherlands

Site Status

Medisch Centrum Leeuwarden

Leeuwarden, , Netherlands

Site Status

Leids Universitair Medisch Centrum

Leiden, , Netherlands

Site Status

St. Antonius Ziekenhuis

Nieuwegein, , Netherlands

Site Status

Universitair Medisch Centrum Utrecht

Utrecht, , Netherlands

Site Status

King Faisal Specialist Hospital & Research Center

Riyadh, , Saudi Arabia

Site Status

Prince Salman Heart Centre - King Fahad Medical City

Riyadh, , Saudi Arabia

Site Status

University Medical Centre Ljubljana

Ljubljana, , Slovenia

Site Status

Milpark Hospital

Johannesburg, , South Africa

Site Status

Hospital De Cruces

Barakaldo, , Spain

Site Status

Hospital Universitario 12 de Octubre

Madrid, , Spain

Site Status

Hospital Universitario Puerta de Hierro Majadahonda

Majadahonda, , Spain

Site Status

Complejo Hospitalario Universitario de Vigo (CHUVI) - Hospital del Meixoeiro

Vigo, , Spain

Site Status

Universitetssjukhuset i Lund

Lund, , Sweden

Site Status

Universitetssjukhuset Örebro

Örebro, , Sweden

Site Status

Capio S:t Görans Sjukhus

Stockholm, , Sweden

Site Status

Cardio Centro Ticino

Lugano, , Switzerland

Site Status

Sheikh Khalifa Medical Center

Abu Dhabi, , United Arab Emirates

Site Status

Royal Bournemouth Hospital

Bournemouth, , United Kingdom

Site Status

Liverpool Heart and Chest Hospital NHS Foundation Trust

Liverpool, , United Kingdom

Site Status

King's College Hospital NHS Foundation Trust

London, , United Kingdom

Site Status

Southampton General Hospital - University Hospital Southampton NHS Foundation Trust

Southampton, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Chile Finland Puerto Rico United States Austria Canada Colombia Czechia Denmark Germany India Israel Italy Japan Malaysia Netherlands Saudi Arabia Slovenia South Africa Spain Sweden Switzerland United Arab Emirates United Kingdom

References

Explore related publications, articles, or registry entries linked to this study.

Auricchio A, Meijer A, Kurita T, Schloss E, Brinkman K, Claessens-van Ooijen M, Sterns L. Safety, efficacy, and performance of new discrimination algorithms to reduce inappropriate and unnecessary shocks: the PainFree SST clinical study design. Europace. 2011 Oct;13(10):1484-93. doi: 10.1093/europace/eur133. Epub 2011 Jun 13.

Reference Type BACKGROUND
PMID: 21669960 (View on PubMed)

Auricchio A, Schloss EJ, Kurita T, Meijer A, Gerritse B, Zweibel S, AlSmadi FM, Leng CT, Sterns LD; PainFree SST Investigators. Low inappropriate shock rates in patients with single- and dual/triple-chamber implantable cardioverter-defibrillators using a novel suite of detection algorithms: PainFree SST trial primary results. Heart Rhythm. 2015 May;12(5):926-36. doi: 10.1016/j.hrthm.2015.01.017. Epub 2015 Jan 28.

Reference Type RESULT
PMID: 25637563 (View on PubMed)

Sterns LD, Meine M, Kurita T, Meijer A, Auricchio A, Ando K, Leng CT, Okumura K, Sapp JL, Brown ML, Lexcen DR, Gerritse B, Schloss EJ. Extended detection time to reduce shocks is safe in secondary prevention patients: The secondary prevention substudy of PainFree SST. Heart Rhythm. 2016 Jul;13(7):1489-96. doi: 10.1016/j.hrthm.2016.03.022. Epub 2016 Mar 14.

Reference Type RESULT
PMID: 26988379 (View on PubMed)

Wollmann CG, Lawo T, Kuhlkamp V, Becker R, Garutti C, Jackson T, Brown ML, Mayr H. Implantable defibrillators with enhanced detection algorithms: detection performance and safety results from the PainFree SST study. Pacing Clin Electrophysiol. 2014 Sep;37(9):1198-209. doi: 10.1111/pace.12390. Epub 2014 Mar 25.

Reference Type RESULT
PMID: 24665992 (View on PubMed)

Zweibel S, Cronin EM, Schloss EJ, Auricchio A, Kurita T, Sterns LD, Gerritse B, Lexcen DR, Cheng A. Estimating the incidence of atrial fibrillation in single-chamber implantable cardioverter defibrillator patients. Pacing Clin Electrophysiol. 2019 Feb;42(2):132-138. doi: 10.1111/pace.13555. Epub 2018 Dec 13.

Reference Type DERIVED
PMID: 30478983 (View on PubMed)

Kurita T, Ando K, Ueda M, Shizuta S, Okamura H, Matsumoto N, Gerritse B, Fagan DH, Schloss EJ, Meijer A, Auricchio A, Sterns LD, Okumura K; PainFree SST investigators. Comparison of ICD shock rates in Japanese and non-Japanese patients in the PainFree SST study. Pacing Clin Electrophysiol. 2018 Sep;41(9):1185-1191. doi: 10.1111/pace.13427. Epub 2018 Aug 13.

Reference Type DERIVED
PMID: 29928759 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PainFree SST

Identifier Type: -

Identifier Source: org_study_id